Biora Therapeutics, Inc. Operating Expenses
Biora Therapeutics, Inc. reported Operating Expenses of $16.26 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2024-11-14
- Biora Therapeutics, Inc. operating expenses for the quarter ending 2024-09-30 was $16.26M, a 30.28% decline year-over-year.
- Biora Therapeutics, Inc. operating expenses for the quarter ending 2024-06-30 was $16.10M, a 7.82% increase year-over-year.
- Biora Therapeutics, Inc. operating expenses for the quarter ending 2024-03-31 was $16.06M, a 3.29% increase year-over-year.
- Biora Therapeutics, Inc. operating expenses for the quarter ending 2023-12-31 was $13.34M, a 3.23% decline year-over-year.
- Biora Therapeutics, Inc. operating expenses for fiscal 2023 was $67.15M, a 8.15% increase from fiscal 2022.
- Biora Therapeutics, Inc. operating expenses for fiscal 2022 was $62.09M, a 47.86% decline from fiscal 2021.
- Biora Therapeutics, Inc. operating expenses for fiscal 2021 was $119.08M, a 10.49% increase from fiscal 2020.
- Biora Therapeutics, Inc. operating expenses for fiscal 2020 was $107.78M, a 41.30% decline from fiscal 2019.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | $16.26M 10-Q · filed 2024-11-14 | $32.36M derived: sum of 2 quarters · filed 2024-11-14 | $48.42M 10-Q · filed 2024-11-14 | $61.77M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2024-06-30 | $16.10M 10-Q · filed 2024-08-12 | $32.16M 10-Q · filed 2024-08-12 | $45.51M derived: sum of 3 quarters · filed 2024-08-12 | $68.83M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2024-03-31 | $16.06M 10-Q · filed 2024-05-15 | $29.40M derived: sum of 2 quarters · filed 2024-05-15 | $52.72M derived: sum of 3 quarters · filed 2024-11-14 | $67.66M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-12-31 | $13.34M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $36.66M derived: sum of 2 quarters · filed 2024-11-14 | $51.60M derived: sum of 3 quarters · filed 2024-11-14 | $67.15M 10-K · filed 2024-04-01 | ||||
| 2023-09-30 | $23.32M 10-Q · filed 2024-11-14 | $38.26M derived: sum of 2 quarters · filed 2024-11-14 | $53.80M 10-Q · filed 2024-11-14 | $67.59M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $14.94M 10-Q · filed 2024-08-12 | $30.48M 10-Q · filed 2024-08-12 | $44.27M derived: sum of 3 quarters · filed 2024-08-12 | $58.24M derived: sum of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | $15.55M 10-Q · filed 2024-05-15 | $29.34M derived: sum of 2 quarters · filed 2024-05-15 | $43.30M derived: sum of 3 quarters · filed 2024-05-15 | $57.62M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $13.79M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $27.76M derived: sum of 2 quarters · filed 2024-04-01 | $42.07M derived: sum of 3 quarters · filed 2024-04-01 | $62.09M 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | $13.97M 10-Q · filed 2023-11-13 | $28.28M derived: sum of 2 quarters · filed 2023-11-13 | $48.30M 10-Q · filed 2023-11-13 | $68.89M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | $14.31M 10-Q · filed 2023-08-14 | $34.33M 10-Q · filed 2023-08-14 | $54.92M derived: sum of 3 quarters · filed 2023-08-14 | $85.67M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $20.02M 10-Q · filed 2023-05-15 | $40.61M derived: sum of 2 quarters · filed 2023-05-15 | $71.35M derived: sum of 3 quarters · filed 2023-05-15 | $107.47M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $20.59M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $51.34M derived: sum of 2 quarters · filed 2023-03-30 | $87.45M derived: sum of 3 quarters · filed 2023-03-30 | $119.08M 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | $30.74M 10-Q · filed 2022-11-14 | $66.86M derived: sum of 2 quarters · filed 2022-11-14 | $98.49M 10-Q · filed 2022-11-14 | $124.42M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $36.12M 10-Q · filed 2022-08-15 | $67.75M 10-Q · filed 2022-08-15 | $93.67M derived: sum of 3 quarters · filed 2022-08-15 | $124.40M derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | $31.63M 10-Q · filed 2022-05-10 | $48.54M 10-Q · filed 2021-05-13 | $57.56M derived: sum of 2 quarters · filed 2022-05-10 | $88.28M derived: sum of 3 quarters · filed 2022-05-10 | $114.76M derived: sum of 4 quarters · filed 2022-05-10 | |||
| 2020-12-31 | $25.93M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $56.65M derived: sum of 2 quarters · filed 2022-03-28 | $83.13M derived: sum of 3 quarters · filed 2022-03-28 | $107.78M 10-K · filed 2022-03-28 | $176.07M 10-K · filed 2021-03-18 | |||
| 2020-09-30 | $30.72M 10-Q · filed 2021-11-10 | $46.91M 10-Q · filed 2020-11-09 | $57.20M derived: sum of 2 quarters · filed 2021-11-10 | $81.85M 10-Q · filed 2021-11-10 | $131.85M 10-Q · filed 2020-11-09 | $144.48M derived: sum of 4 quarters · filed 2021-11-10 | ||
| 2020-06-30 | $26.48M 10-Q · filed 2021-08-12 | $42.15M 10-Q · filed 2020-08-14 | $51.13M 10-Q · filed 2021-08-12 | $84.94M 10-Q · filed 2020-08-14 | $113.75M derived: sum of 3 quarters · filed 2021-08-12 | $162.37M derived: sum of 4 quarters · filed 2021-08-12 | ||
| 2020-03-31 | $42.78M 10-Q · filed 2021-05-13 | $87.27M derived: sum of 2 quarters · filed 2021-05-13 | $135.89M derived: sum of 3 quarters · filed 2021-05-13 | $181.30M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $44.49M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $93.10M derived: sum of 2 quarters · filed 2021-03-18 | $138.52M derived: sum of 3 quarters · filed 2021-03-18 | $183.61M 10-K · filed 2021-03-18 | ||||
| 2019-09-30 | $48.62M 10-Q · filed 2020-11-09 | $94.03M derived: sum of 2 quarters · filed 2020-11-09 | $139.12M 10-Q · filed 2020-11-09 | |||||
| 2019-06-30 | $45.41M 10-Q · filed 2020-08-14 | $90.51M 10-Q · filed 2020-08-14 |